Cargando…

Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study

OBJECTIVE: Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID. DESIGN: A nationwide cohort study. Using a centralized dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Limor, Gazit, Sivan, Pinto, Yuval, Perez, Galit, Mizrahi Reuveni, Miri, Yehoshua, Ilan, Hoffman, Robert, Azuri, Joseph, Patalon, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848375/
https://www.ncbi.nlm.nih.gov/pubmed/36314555
http://dx.doi.org/10.1080/02813432.2022.2139480
_version_ 1784871695734013952
author Adler, Limor
Gazit, Sivan
Pinto, Yuval
Perez, Galit
Mizrahi Reuveni, Miri
Yehoshua, Ilan
Hoffman, Robert
Azuri, Joseph
Patalon, Tal
author_facet Adler, Limor
Gazit, Sivan
Pinto, Yuval
Perez, Galit
Mizrahi Reuveni, Miri
Yehoshua, Ilan
Hoffman, Robert
Azuri, Joseph
Patalon, Tal
author_sort Adler, Limor
collection PubMed
description OBJECTIVE: Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID. DESIGN: A nationwide cohort study. Using a centralized database, we have identified patients with and without a history of SARS-CoV-2 infection 1–6 months before data collection. Patients were asked to fill out an online questionnaire through text messages. SETTING: Israeli general practice. SUBJECTS: 2755 persons participated in the study in September 2021 (a response rate of 7.5%): 819 with and, 936 without a history of SARS-CoV-2 infection. MAIN OUTCOME MEASURES: We asked patients to provide details about their demographic status, medical history, COVID-related variables and the presence of long-COVID symptoms. RESULTS: Most prevalent long-COVID symptoms were decreased smell sensation (35.1% vs. 4.3%, p < 0.001), decreased taste sensation (25.2% vs. 3.2%, p < 0.001), memory disturbances (36.9% vs. 14.4%, p < 0.001), dyspnea (24.2% vs. 10.7%, p < 0.001) and arthralgia (33% vs. 16.3%, p < 0.001). Risk factors associated with long-COVID included female gender, symptomatic COVID-19, overweight or obesity and the presence of dyslipidemia. About 34.6% of participants reported not returning to their baseline health condition after the acute illness. CONCLUSION: Long-COVID is frequently seen following a mild symptomatic COVID-19 infection and, to a lesser extent, following an asymptomatic SARS-CoV-2 infection. Primary care physicians should be aware of these symptoms and consider this option in their differential diagnosis. Health policymakers should expect a significant impact of this syndrome on public health. KEY POINTS: Long-COVID has emerged as a significant health problem with a serious impact on normal daily function; • Long-COVID symptoms were evident in patients with mild symptomatic disease and in asymptomatic patients to a lesser extent. • Risk factors for having Long-COVID symptoms include female gender, symptomatic disease, increased BMI, and the presence of dyslipidemia. • Fatigue, dyspnea, weakness, decreased libido, weight changes, memory, and sleep disturbances were associated with not returning to the baseline health state.
format Online
Article
Text
id pubmed-9848375
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-98483752023-01-19 Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study Adler, Limor Gazit, Sivan Pinto, Yuval Perez, Galit Mizrahi Reuveni, Miri Yehoshua, Ilan Hoffman, Robert Azuri, Joseph Patalon, Tal Scand J Prim Health Care Original Articles OBJECTIVE: Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID. DESIGN: A nationwide cohort study. Using a centralized database, we have identified patients with and without a history of SARS-CoV-2 infection 1–6 months before data collection. Patients were asked to fill out an online questionnaire through text messages. SETTING: Israeli general practice. SUBJECTS: 2755 persons participated in the study in September 2021 (a response rate of 7.5%): 819 with and, 936 without a history of SARS-CoV-2 infection. MAIN OUTCOME MEASURES: We asked patients to provide details about their demographic status, medical history, COVID-related variables and the presence of long-COVID symptoms. RESULTS: Most prevalent long-COVID symptoms were decreased smell sensation (35.1% vs. 4.3%, p < 0.001), decreased taste sensation (25.2% vs. 3.2%, p < 0.001), memory disturbances (36.9% vs. 14.4%, p < 0.001), dyspnea (24.2% vs. 10.7%, p < 0.001) and arthralgia (33% vs. 16.3%, p < 0.001). Risk factors associated with long-COVID included female gender, symptomatic COVID-19, overweight or obesity and the presence of dyslipidemia. About 34.6% of participants reported not returning to their baseline health condition after the acute illness. CONCLUSION: Long-COVID is frequently seen following a mild symptomatic COVID-19 infection and, to a lesser extent, following an asymptomatic SARS-CoV-2 infection. Primary care physicians should be aware of these symptoms and consider this option in their differential diagnosis. Health policymakers should expect a significant impact of this syndrome on public health. KEY POINTS: Long-COVID has emerged as a significant health problem with a serious impact on normal daily function; • Long-COVID symptoms were evident in patients with mild symptomatic disease and in asymptomatic patients to a lesser extent. • Risk factors for having Long-COVID symptoms include female gender, symptomatic disease, increased BMI, and the presence of dyslipidemia. • Fatigue, dyspnea, weakness, decreased libido, weight changes, memory, and sleep disturbances were associated with not returning to the baseline health state. Taylor & Francis 2022-10-31 /pmc/articles/PMC9848375/ /pubmed/36314555 http://dx.doi.org/10.1080/02813432.2022.2139480 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Adler, Limor
Gazit, Sivan
Pinto, Yuval
Perez, Galit
Mizrahi Reuveni, Miri
Yehoshua, Ilan
Hoffman, Robert
Azuri, Joseph
Patalon, Tal
Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
title Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
title_full Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
title_fullStr Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
title_full_unstemmed Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
title_short Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
title_sort long-covid in patients with a history of mild or asymptomatic sars-cov-2 infection: a nationwide cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848375/
https://www.ncbi.nlm.nih.gov/pubmed/36314555
http://dx.doi.org/10.1080/02813432.2022.2139480
work_keys_str_mv AT adlerlimor longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT gazitsivan longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT pintoyuval longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT perezgalit longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT mizrahireuvenimiri longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT yehoshuailan longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT hoffmanrobert longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT azurijoseph longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy
AT patalontal longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy